A pilot study of prospective observational cohort study to assess the profile of OAD dual combination therapy in patients with T2DM in real practice

Chonnam National University Hospital0 个研究点目标入组 288 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•Male or female patients = 18 years
•- Patients diagnosed with type 2 DM, on metformin monotherapy, who will be prescribed a new OAD or an OAD fixed-dose combination as dual combination therapy according to local label/prescribing requirements.
•- 7=HbA1c=11
•- Patients give informed consent to have their data collected and agree to follow prescribing requirements

•- Patients who require three or more OAD or insulin at time of study entry.
•- Patients who are switched from
•one OAD or class to another at time of study entry.
•- History of hypersensitivity to any of the study drug.
•- Patients who are attending other study and use of any drug.
•- Patients who are taking SUs other than glimepiride at study entry
•-Patients for whom the investigator would consider another SU than glimepiride during the course of the trial
•- Patients treated with glinides at study entry
•-patients for which a treatment with glinides would be considered during the course of the study

发起方